Combat Medical
Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer
£2.6MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer